Date Filed | Type | Description |
02/27/2023 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
02/24/2023 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns:
| Granted 3,882 shares
@ $0 Disposed/sold 3,882 restricted stock units
@ $0 |
|
02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns:
| Granted 4,222 shares
@ $0 Disposed/sold 4,222 restricted stock units
@ $0 |
|
08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/26/2018 |
4
| SIEBERT JOHN M (Interim Principal Exec Ofcr) has filed a Form 4 on ARADIGM CORP
Txns:
| Granted 276,000 options to buy
@ $1.31, valued at
$361.6k
|
|
02/27/2018 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Granted 8,613 options to buy
@ $39.4, valued at
$339.4k
|
|
06/15/2017 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Granted 6,036 options to buy
@ $38.6, valued at
$233k
|
|
06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/27/2017 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2016 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Granted 15,000 options to buy
@ $12.98, valued at
$194.7k
|
|
11/16/2015 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns:
| Granted 19,940 options to buy
@ $6.5, valued at
$129.6k
|
|
03/05/2015 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Granted 20,000 options to buy
@ $9.13, valued at
$182.6k
|
|
01/13/2015 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Exercised 2,188 options to buy
@ $4.24, valued at
$9.3k
|
|
04/22/2014 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns:
| Granted 225,000 options to buy
@ $0.22, valued at
$49.5k
|
|
01/23/2014 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns:
| Exercised 2,187 options to buy
@ $4.24, valued at
$9.3k
Granted 7,457 options to buy
@ $9.24, valued at
$68.9k
|
|
06/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/25/2013 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
12/17/2012 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
06/01/2012 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns:
| Granted 100,000 shares
@ $0 Granted 140,000 options to buy
@ $0.15, valued at
$21k
|
|
04/30/2012 |
3
| SIEBERT JOHN M (Director) has filed a Form 3 on SUPERNUS PHARMACEUTICALS INC |
05/31/2011 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns:
| Granted 78,947 shares
@ $0 Granted 100,000 options to buy
@ $0.19, valued at
$19k
|
|
05/18/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/05/2009 |
4/A
| Form 4/A -- Statement of changes in beneficial ownership of securities [amend] |
05/19/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |